Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/15962
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAl-Mozaini, M-
dc.contributor.authorTsolaki, AG-
dc.contributor.authorAbdul-Aziz, M-
dc.contributor.authorAbozaid, SM-
dc.contributor.authorAl-Ahdal, MN-
dc.contributor.authorPathan, AA-
dc.contributor.authorMurugaiah, V-
dc.contributor.authorMakarov, EM-
dc.contributor.authorKaur, A-
dc.contributor.authorSim, RB-
dc.contributor.authorKishore, U-
dc.contributor.authorKouser, L-
dc.date.accessioned2018-03-12T15:54:20Z-
dc.date.available2018-03-12T15:54:20Z-
dc.date.issued2018-05-08-
dc.identifier.citationAl-Mozaini MA, Tsolaki AG, Abdul-Aziz M, Abozaid SM, Al-Ahdal MN, Pathan AA, Murugaiah V, Makarov EM, Kaur A, Sim RB, Kishore U and Kouser L (2018) Human Properdin Modulates Macrophage: Mycobacterium bovis BCG Interaction via Thrombospondin Repeats 4 and 5. Front. Immunol. 9:533.en_US
dc.identifier.issn1664-3224-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/15962-
dc.description.abstractMycobacterium tuberculosis can proficiently enter macrophages and diminish complement activation on its cell surface. Within macrophages, the mycobacterium can suppress macrophage apoptosis and survive within the intracellular environment. Previously, we have shown that complement regulatory proteins such as factor H may interfere with pathogen–macrophage interactions during tuberculosis infection. In this study, we show that Mycobacterium bovis BCG binds properdin, an upregulator of the complement alternative pathway. TSR4+5, a recombinant form of thrombospondin repeats 4 and 5 of human properdin expressed in tandem, which is an inhibitor of the alternative pathway, was also able to bind to M. bovis BCG. Properdin and TSR4+5 were found to inhibit uptake of M. bovis BCG by THP-1 macrophage cells in a dose-dependent manner. Quantitative real-time PCR revealed elevated pro-inflammatory responses (TNF-α, IL-1β, and IL-6) in the presence of properdin or TSR4+5, which gradually decreased over 6 h. Correspondingly, anti-inflammatory responses (IL-10 and TGF-β) showed suppressed levels of expression in the presence of properdin, which gradually increased over 6 h. Multiplex cytokine array analysis also revealed that properdin and TSR4+5 significantly enhanced the pro-inflammatory response (TNF-α, IL-1β, and IL-1α) at 24 h, which declined at 48 h, whereas the anti-inflammatory response (IL-10) was suppressed. Our results suggest that properdin may interfere with mycobacterial entry into macrophages via TSR4 and TSR5, particularly during the initial stages of infection, thus affecting the extracellular survival of the pathogen. This study offers novel insights into the non-complement related functions of properdin during host–pathogen interactions in tuberculosis.en_US
dc.description.sponsorshipMA-A has been supported by the Ministry of Higher Education, Malaysia and the Universiti Sains Malaysia.-
dc.language.isoenen_US
dc.subjectComplement-
dc.subjectCytokine-
dc.subjectProperdin-
dc.subjectMacrophage-
dc.subjectMycobacterium tuberculosis-
dc.subjectMycobacterium bovis BCG-
dc.subjectPhagocytosis-
dc.subjectThrombospondin repeats-
dc.titleHuman properdin modulates macrophage: Mycobacterium bovis BCG interaction via thrombospondin repeats (TSR) 4 and 5en_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.3389/fimmu.2018.00533-
dc.relation.isPartOfFrontiers in Immunology-
pubs.publication-statusPublished-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdf2.87 MBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.